Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jan 20.
Published in final edited form as: Behav Genet. 2015 Aug 29;46(1):20–30. doi: 10.1007/s10519-015-9736-4

G×E Interaction Influences Trajectories of Hand Grip Strength

Inge Petersen 1,, Nancy L Pedersen 2, Taina Rantanen 3, William S Kremen 4,5, Wendy Johnson 6, Matthew S Panizzon 4, Lene Christiansen 1, Carol E Franz 4, Matt McGue 1,7, Kaare Christensen 1,8,9, Nayla R Hamdi 7, Robert F Krueger 7, Chandra Reynolds 10
PMCID: PMC4720577  NIHMSID: NIHMS733350  PMID: 26318288

Abstract

Age-related decline in grip strength predicts later life disability, frailty, lower well-being and cognitive change. While grip strength is heritable, genetic influence on change in grip strength has been relatively ignored, with non-shared environmental influence identified as the primary contributor in a single longitudinal study. The extent to which gene-environment interplay, particularly gene-environment interactions, contributes to grip trajectories has yet to be examined. We considered longitudinal grip strength measurements in seven twin studies of aging in the Interplay of Genes and Environment across Multiple Studies consortium. Growth curve parameters were estimated for same-sex pairs, aged 34–99 (N = 10,681). Fisher's test for mixture distribution of within-monozy-gotic twin-pair differences (N = 1724) was performed on growth curve parameters. We observed significant gene-environment interaction on grip strength trajectories. Finally, we compared the variability of within-pair differences of growth curve parameters by APOE haplotypes. Though not statistically significant, the results suggested that APOE ε2ε2/ε2ε3 haplotypes might buffer environmental influences on grip strength trajectories.

Keywords: Grip strength, Gene-environment interaction, Twins, APOE

Introduction

Age-related loss of skeletal muscle mass has been associated with several adverse age-related outcomes including higher risk of mortality (Cruz-Jentoft et al. 2010b). The age-related loss of muscle mass is due to decreasing number and size of myofibres, but the process can be slowed down or even reversed by exercise and dietary supplements (Sayer et al. 2013). Hand grip strength has been shown to correlate with elbow flexion strength as well as knee and trunk extension strength (Tiainen et al. 2004), and it has been recommended as the best technique for measuring muscle strength (Cruz-Jentoft et al. 2010a). However, in a recent study of elderly women, the usefulness of grip strength as a proxy measure of muscle strength in lower extremities was questioned (Felicio et al. 2014). The existing literature provides evidence that grip strength reflects a mixture of genetic predispositions, environmental factors, and diseases. Indeed, grip strength has been suggested to be a more powerful single marker of frailty than chronological age in a group of elderly (Syddall et al. 2003).

Grip strength is easily measured in the clinic or at home-visits and is among the most studied phenotypes in the literature on phenotypes of aging. A comprehensive literature provides evidence that grip strength is a strong predictor of adverse outcomes in elderly people. Poor grip strength has been demonstrated to predict disability in activities of daily living (ADL) (Taekema et al. 2010; den Ouden et al. 2013; Rantanen et al. 1999), persisting depression and anxiety disorders (van Milligen et al. 2012), depression (Gatz et al. 2010), lower cognitive performance (Sternang et al. 2015b), reduced social and leisure activities among the oldest old (Taekema et al. 2010), higher risk of being hospitalized (Legrand et al. 2014) and longer stays at hospital (Mendes et al. 2014). Moreover, several studies have established an association between low grip strength and higher mortality rates (Legrand et al. 2014; Rantanen et al. 2012; Cooper et al. 2014; Rantanen et al. 2000, 2003).

Grip strength is a measure that captures early and recent exposures and depends on internal factors such as age and sex (Nahhas et al. 2010; Rantanen et al. 2000; Frederiksen et al. 2006; Sternang et al. 2015a). Men were significantly stronger, but they also demonstrated steeper decline compared to women (Frederiksen et al. 2006; Nahhas et al. 2010; Sternang et al. 2015a). Moreover, Nahhas et al. (2010) found that the decline in grip strength begins in midlife and continues throughout life, which is consistent with another study suggesting accelerating declines in late life for men and women (Sternang et al. 2015a). Moreover, as suggested in a phenotypic study of Swedish twins, grip strength trajectories might be affected by different environmental factors in men and women (e.g. marital status had significant impact for men only, depression and dementia for women only) (Sternang et al. 2015a).

Previous studies have estimated that the heritability of grip strength is approximately 50–60 % (Frederiksen et al. 2002; Silventoinen et al. 2008), and a Swedish longitudinal study of grip strength found that the heritability was higher in men (75 %) than in women (47 %) (Finkel et al. 2003). Moreover, two studies based on Danish and Swedish twin data, respectively, have reported relatively constant heritability across the age range 45–96 years (Finkel et al. 2003; Frederiksen et al. 2002). Revisiting the Danish twin data using age as a continuous variable, McGue et al. established a slightly curvilinear heritability of grip strength across ages 45–96 years, the maximum heritability being observed in the youngest (approximately 60 %) and reaching a minimum heritability of approximately 50 % at age 70 years (McGue and Christensen 2013). Only one longitudinal study has investigated the heritability of decline over a 9-year period (three follow-up assessments) of grip strength in Swedish twins aged 50–96 years at baseline and found that for neither men nor women did genes have a significant contribution to the age-related decline of grip strength (Finkel et al. 2003).

Despite the relatively substantial heritability of grip strength, few associations with particular genotypes have been reported. However, the literature does suggest that the APOE gene is associated with physical performance in aging populations. Thus, in a longitudinal study over 12 years, APOE ε2 carriershad less decline in grip strength than APOE ε3 carriers, whereas the decline of APOE ε4 carriers did not differ significantly from that of APOE ε3 carriers, however in right hand measurements only (Batterham et al. 2013). Two studies have reported a statistically non-significant tendency towards APOE ε2ε2/ε2ε3 being associated with lower grip strength and APOE ε3ε4/ε4ε4 being associated with greater grip strength compared to APOE ε3ε3/ε4ε2 (Vasunilashorn et al. 2013; Alfred et al. 2014). Another study has reported associations between the APOE gene and Activities of Daily Living (ADL)—a phenotype often used in aging studies and which partly captures muscle strength. The study demonstrated that in men APOE ε3ε3 decreased the risk of ADL disability and APOE ε2ε3 increased the risk of disability of Instrumental Activities of Daily Living (IADL); however, in women APOE ε4ε4 carriers had a significantly decreased risk of ADL disability (Kulminski et al. 2008) compared to APOE ε4ε4 non-carriers. This latter study demonstrates that APOE haplotypes might have different impact on physical decline in men and women.

The primary aim of this study was to establish whether grip strength trajectories were affected by gene-environment (G×E) interaction and, secondly, if the first test was confirmative, to examine whether the APOE gene could be a possible candidate gene for the G×E interaction. Since monozygotic (MZ) twins have all genes in common, within-pair differences cannot be ascribed to genetic effects or shared environmental factors, leaving non-shared environmental factors only. First, we tested whether differences in grip strength trajectories, obtained from growth curve modeling of maximum grip strength performance, exhibited evidence of a mixture distribution. Secondly, we tested whether the variability of MZ within-pair differences of grip strength trajectories differs as a function of APOE haplotype categories. Confirmative results of this test will provide evidence of G×E interaction, i.e., evidence that genes in general, or APOE haplotypes specifically, enhance or reduce the involvement of unspecified environmental factors on grip strength trajectories.

Methods

Participants

The sample comprised twin data from seven individual studies representing four countries: two from the United States, two from Sweden, one from Finland, and two from Denmark. Five studies had longitudinal grip strength measurements (Table 1). All seven studies are part of the Interplay of Genes and Environment across Multiple Studies (IGEMS) consortium (Pedersen et al. 2013).

Table 1. Sample characteristics by study.

Study Number of individual twins in each wavea Male (%) Age range (median) at baseline Max (median) number of grip strength measurements Number of MZ pairs Number of MZ pairs with APOE genotype
VETSA (USA) 1215 100 51–60 (54) 1 (1) 311 308
MIDUS (USA) 379 41 34–82 (53) 1 (1) 81
SATSA (Sweden) 851; 741; 646; 468; 322; 232; 141 41 39–88 (63) 7 (4) 153 133
OCTO (Sweden) 640; 511; 383; 274; 190 34 79–99 (82) 5 (3) 127 113
FITSA (Finland) 434; 308 0 63–79 (69) 2 (1) 103 101
MADT (Denmark) 4276; 2358 51 45–77 (56) 2 (2) 657 386
LSADT (Denmark) 2886; 2121; 1585; 882 45 70–97 (75) 4 (3) 292 100
Total 10,681 51 34–99 (66) 7 (1) 1724 1141

VETSA Vietnam Era Twin Study of Aging, MIDUS Midlife Development in the United States, SATSA Swedish Adoption/Twin Study of Aging, OCTO Origins of Variance in the Oldest-Old, FITSA Finnish Twin Study of Aging, MADT Middle Aged Danish Twins, LSADT Longitudinal Study of Aging Danish Twins

a

Including broken pairs

United States studies

The two studies from the United States were the Vietnam Era Twin Study of Aging (VETSA) (Kremen et al. 2013) and the twin sample from Midlife Development in the United States (MIDUS) (Kendler et al. 2000). Both were longitudinal, but grip strength data were available from one occasion only. The VETSA study comprised male twin pairs aged 51–60 years at first assessment, and the age range of the twins from MIDUS, which included both sexes, was 34–82 years.

Swedish studies

Ascertainment of the two Swedish studies was based on records from The Swedish Twin Registry (Lichtenstein et al. 2002) and included the longitudinal studies Swedish Adoption/Twin Study of Aging (SATSA) (Pedersen et al. 1991) and the twins from the study Origins of Variance in the Oldest-Old (OCTO) (McClearn et al. 1997). Participants of the SATSA in-person tests were 39–88 years of age at first assessment and were reassessed at 3-year intervals and maximum seven times. The OCTO participants were 79–99 years of age at first assessment and were revisited a maximum of four times at 2-year intervals.

Finnish study

The participants of the Finnish Twin Study on Aging (FITSA) were recruited from the Finnish Twin Cohort (Tiainen et al. 2004). Selected on the basis of age and zygosity only, 414 same-sex female twin pairs from the Finnish Twin Study on Aging (FITSA) were recruited for clinical examination at age 63–76 years. Only pairs where both twins agreed to participate were invited for an examination. Survivors were invited for a second clinical examination 3 years later.

Danish studies

The Danish studies included the Longitudinal Study of Aging Danish Twins (LSADT) (Christensen et al. 1999) and the study of Middle-Aged Danish Twins (MADT) (Skytthe et al. 2013). Participants in these two studies were recruited from the Danish Twin Register which contains all identifiable twins born since 1870 (Skytthe et al. 2002). LSADT participants were 70–100 years and MADT participants were 45–68 years at first assessment. The LSADT study was initiated in 1995 and surviving participants, along with twins from younger birth cohorts, were invited for consecutive interviews every second year. Initially, the LSADT participants were same-sex twins aged 75?, but the inclusion age was progressively dropped to age 70 in 1999. Grip strength was not part of the battery until the 1999 survey. The MADT study comprised same-sex and opposite-sex twins who were visited in 1998, and surviving twins were invited to participate in a follow-up study 10 years later.

The total sample comprised 10,681 individual twins 34–99 years of age, including 1724 same-sex MZ twin pairs with grip strength measurements; 1141 of these pairs were genotyped for APOE (Table 1). All analyses were carried out separately for each sex as previous studies have demonstrated that heritability (Finkel et al. 2003) of grip strength and type of environmental factors influencing grip strength trajectories (Sternang et al. 2015a) vary between sexes.

Measures

Grip strength

Grip strength was measured at in-person testing by trained interviewers; however, the protocols and the brand of the measuring devises differed among studies:

United States studies (MIDUS and VETSA)

In VETSA, grip strength was assessed using a JAMAR handheld dynamometer. The participants were seated in a study chair parallel to a table, resting one arm on the table while sitting with their back straight. The arm was positioned with the elbow flexed to 90 degrees and the wrist resting just off the end of the table. Participants were coached to push as hard as possible to obtain peak performance. The largest integer which the needle passed was recorded in kg. This was repeated, using alternating hands, starting with the dominant hand, until three trials were obtained for each hand.

In MIDUS, grip strength was measured (as part of MIDUS II) in six attempts (three on each hand) by a handheld dynamometer and always right hand first. The participant was instructed to support the elbow on a table, arm of chair or knee and squeeze as hard as possible until the measurement needle stopped moving.

Swedish studies (SATSA and OCTO)

In SATSA, grip strength was measured using a Collins dynamometer at sessions at a location convenient for the twin (Pedersen et al. 1991). The participants were placed in a seated position using a table as support for the elbow (Sternang et al. 2015a) and had three trials on each hand.

In OCTO-twin, a Martin balloon dynamometer was used to measure grip strength at home-based interviews performed by nurses. The bulb of the dynamometer was adjusted to the hand size, and the arm rested on a table at a 45 degree angle (Proctor et al. 2006). The participants had three trials on each hand.

Finnish study (FITSA)

In FITSA, grip strength was measured using a dynamometer fixed to a chair. Maximal grip strength was measured at three to five attempts. The tests were done by trained physiotherapists (Tiainen et al. 2004).

Danish studies (MADT and LSADT)

In the two Danish studies, a handheld Smedley dynamometer was used and grip strength was measured three times on each hand during home-based interviews performed by trained lay-interviewers. The handle was adjusted to fit the size of the hand, and the participants were instructed to squeeze as hard as possible while holding their arm tight to the body and arm flexed in a 90 degree angle. The participant could choose a sitting or standing position during the test (Frederiksen et al. 2006).

In the seven studies, maximum grip strength measurements were obtained for each participant. Due to the differing procedures for grip strength measurements among the studies, all analyses were performed on standardized maximum grip strength measurements. The standardization was based on sex- and study-specific means and standard deviations from the first available waves in the respective studies (mean zero and standard deviation of 10).

APOE-genotyping

Genotyping of the APOE gene was performed in all studies except in MIDUS.

United States studies (VETSA)

In VETSA PCR and the HhaI, restriction digest methods were used to determine APOE genotypes (Schultz et al. 2008).

Swedish studies (SATSA and OCTO)

In the two Swedish studies, the two APOE markers (rs429358 and rs7412) were genotyped separately using Illumina GoldenGate assays (Reynolds et al. 2013).

Finnish study (FITSA)

The APOE genotypes were derived from SNP data obtained from genotyping on the Illumina HumanCoreExome chip, and subsequent imputation to 1000G.

Danish studies (MADT and LSADT)

In the Danish studies, genotyping was not performed on the total twin samples but only on randomly selected samples of the twin pairs. Genotyping of the APOE variants rs429358 and rs7412 were carried out using either custom-made primers and probes (LSADT), or predesigned TaqMan® SNP Genotyping Assays (Applied Biosystems, Foster City, CA, USA) (MADT).

APOE haplotypes were grouped into three categories: APOE ε2ε2 and ε2ε3 (APOE ε2+), APOE ε3ε3, and APOE ε3ε4 and ε4ε4 (APOE ε4+), i.e., APOE ε2ε4 carriers were omitted from further analyses.

Zygosity

For most of the twins, the zygosity determination was based on twin responses to questions regarding similarity in physical appearance, a method whose validity has previously been shown to have an overall misclassification rate of less than 5 % (Christiansen et al. 2003; Krueger and Johnson 2002) For FITSA, VETSA, OCTO, and SATSA zygosity was confirmed by DNA analyses.

Analytic approach

Growth curve estimation

Features of longitudinal trajectories of grip strength were estimated using multilevel mixed linear regression models with full-information maximum likelihood estimation. The growth curve estimation was based on the total twin sample and Best Linear Unbiased Prediction estimates (BLUP's) for intercept, and slope of the standardized grip strength measurements was estimated using age and age-squared (centered at 70 years) entered as fixed effects. The characteristics of the data, i.e., few measurement points on many individuals, did not allow for modelling of the random effect of age-squared, and therefore only linear effect of age was modelled in the random effects. This approach requires a minimum of grip strength measured at one occasion but models grip strength measurements at up to seven occasions. Hence, the intercept reflected the grip performance at age 70 and the linear slope, the ‘tilt’ of the curve, i.e., instantaneous linear rate of change at age 70. The slope parameter was set as missing for individuals who had grip strength measurement at one occasion only. Subsequent analyses were weighted (using the reciprocal standard error) BLUP estimates, resulting in greater weighting of cases with more longitudinal data than those with fewer points. The analyses were conducted on the untransformed weighted estimates as well as on the rank normalized weighted BLUP estimates to avoid spurious G×E interactions (Reynolds et al. 2007). We used Bloms' rank-normalization method (Ludwig 1961) i.e.

normalized estimates=inverse-normal[(ranked-estimates3/8)/(n1/4)]

where n is the number of MZ pairs.

Analyses to evaluate evidence of G×E on grip strength trajectories were performed using MZ intra-pair methods that evaluate the possibility of mixture distributions of pair differences (Fisher 1925) and test for variance homogeneity by genotype (Martin et al. 1983), as applied to longitudinal trajectory phenotypes (Reynolds et al. 2007). While growth curve modeling was based on all twins, the subsequent heterogeneity tests of within-pair differences and variance by APOE haplotypes were constrained to MZ twin pairs. Further description of these methods is provided below.

Heterogeneity test (Fisher)

In 1925 Fisher proposed a test for mixture of distribution based on differences within MZ twin pairs only (Fisher 1925). Fisher's test assumes a Gaussian distribution of the analyzed variable which induces the within-pair difference to follow a Gaussian distribution as well. A significant result of Fisher's test suggests deviations from Gaussian distribution (i.e., the presence of more than a single distribution) of within-twin pair differences. Since MZ twins share all genes, the variation of the within-pair differences can be attributed to unshared environmental factors only. Hence, a significant result of Fisher's test suggests that there are multiple groups of MZ twins who show different responses to unspecified environmental factors. These groups may be characterized by different genotypes, i.e., there is a G×E interaction. The formula for the test statistic is

t=(d2¯π2d¯2)/s

where d2¯ is the mean of the squared within-pair difference, is the mean of within-pair difference, s=d2¯n0.532 is the standard error, and n is the number of MZ twin pairs. The test statistic takes a t-distribution with n − 1 degrees of freedom. Since t is expected to be positive, we used a one-sided t test.

Variance homogeneity test

Among MZ twin pairs only, we performed Bartlett's test to compare the variability of within-twin pair differences of weighted BLUP estimates in three APOE haplotype categories APOE ε2+ (i.e. APOE ε2ε2 or ε2ε3), APOE ε3ε3, and APOE ε4+ (i.e. APOE ε3ε4 or ε4ε4). This test was performed on untransformed as well as rank-normalized weighted BLUP estimates. Moreover, the test was performed on Winsorized estimates (i.e., outliers more than three SDs away from the mean were replaced with values equivalent to three SDs from the mean) to reduce the risk of significant results caused by outliers. Significant heterogeneity indicates that particular APOE haplotypes may be more or less sensitive to environmental factors, i.e., that environmental factors interact with haplotypes of the APOE gene.

Stata version 13 (College Station TX 2013) was used for all statistical analyses.

Results

Summary statistics for the 7 studies are presented in Table 1. Locally weighted regression curves, separately by study, for standardized grip strength on age are shown in Figs. 1 (men) and 2 (women).

Fig.1.

Fig.1

Locally weighted regression curves of the standardized grip strength on age for all men in the total sample as well as in the single studies. The thick gray curve is for the total sample

Fig.2.

Fig.2

Locally weighted regression curves of the standardized grip strength on age for all women in the total sample as well as in the single studies. The thick gray curve is for the total sample

Haplotype distribution by nationality and test for Hardy–Weinberg equilibrium of APOE haplotypes (online calculator: http://www.had2know.com/academics/hardy–weinberg-equilibrium-calculator-3-alleles.html) are given in Table 2. While no deviance from Hardy–Weinberg equilibrium was observed in the Swedish, Finnish, and Danish data, there was evidence of Hardy–Weinberg disequilibrium of the APOE genotypes in the United States data (p = 0.01). However, individual test of the two SNPs did not result in any deviation from the Hardy–Weinberg equilibrium (rs429358: p = 0.79, rs7412: p = 0.05).

Table 2. Frequency count and test for Hardy–Weinberg equilibrium of the total samples of APOE haplotypes by country.

Study APOE haplotypes Total number Hardy–Weinberg Equality

ε2ε2 ε2ε3 ε3ε3 ε2ε4 ε3ε4 ε4ε4 p value
USAa 2 (0.2 %) 110 (12.7 %) 508 (58.5 %) 36 (4.2 %) 193 (22.2 %) 19 (2.2 %) 868 0.01
Swedenb 8 (0.8 %) 139 (13.9 %) 559 (55.8 %) 32 (3.2 %) 240 (24.0 %) 23 (2.3 %) 1001 0.93
Finlandc 1 (0.3 %) 24 (7.3 %) 210 (64.0 %) 6 (1.8 %) 82 (25.0 %) 5 (1.5 %) 328 0.71
Denmarkd 14 (0.6 %) 296 (13.0 %) 1269 (55.7 %) 68 (3.0 %) 568 (24.9 %) 65 (2.9 %) 2280 0.89
Total 25 (0.6 %) 569 (12.7 %) 2546 (56.9 %) 142 (3.2 %) 1083 (24.2 %) 112 (2.5 %) 4477 0.18

One individual from each MZ pair is left out. An online calculator for testing Hardy-Weinberg equilibrium of three alleles was used (http://www.had2know.com/academics/hardy-weinberg-equilibrium-calculator-3-alleles.html)

a

VETSA (Vietnam Era Twin Study of Aging)

b

SATSA (Swedish Adoption/Twin Study of Aging) and OCTO (Origins of Variance in the Oldest-Old)

c

FITSA (Finnish Twin Study of Aging)

d

MADT (Middle Aged Danish Twins) and LSADT (Longitudinal Study of Aging Danish Twins)

Growth curves

Age- and study adjusted mean of growth curve parameters for all twins by APOE haplotypes and sex are reported in Table 3. Though not statistically significant, in men the mean of the intercept was slightly lower in the APOE ε2+ haplotypes, whereas in women the direction was opposite, i.e. APOE ε2+ carriers had the highest intercept, and APOE ε4+ carriers had the lowest intercept. There were no differences in the mean of slopes in the three haplotype categories in men or women.

Table 3. Mean of trajectory features, adjusted for study and age at first assessment, for all twins broken by APOE haplotype and sex.

APOE ε2+ APOE ε3ε3 APOE ε4+ pa



N Mean (95 % CI) N Mean (95 % CI) N Mean (95 % CI)
Men
 Intercept estimates 378 −0.19 (−0.39; 0.02) 1630 0.08 (−0.02; 0.17) 791 −0.07 (−0.19; 0.05) 0.21
 Linear slope estimates 171 0.03 (−0.06; 0.12) 710 0.01 (−0.03; 0.05) 353 −0.03 (−0.09; 0.02) 0.57
Women
 Intercept estimates 371 0.17 (−0.02; 0.35) 1544 0.01 (−0.08; 0.10) 726 −0.11 (−0.24; 0.02) 0.03
 Linear slope estimates 281 0.01 (−0.03; 0.06) 1120 0.00 (−0.02; 0.02) 528 −0.01 (−0.04; 0.02) 0.65

Estimates are weighted Best Linear Unbiased Prediction estimates of trajectory features (see text)

The APOE ε2+ consists of APOE ε2ε2 and APOE ε2ε3 and the APOE ε4+ consists of APOE ε3ε4 and APOE ε4ε4. APOE ε2ε4 is excluded from the analyses

a

p values (ANOVA analyses) for equality of means across APOE groups

Heterogeneity tests

Fisher's test for mixture of distribution adjusted for age and study was highly significant in both sexes for the trajectory features before as well as after rank-normalization. The results indicated that within-pair (MZ pairs only) differences of grip strength trajectories deviated significantly from a single Gaussian distribution; thus the analyses indicated that there are different groups whose grip strength trajectories showed different responses to unspecified environmental factors (Table 4). Hence, we tested whether APOE haplotypes might index the groups that vary in environmental sensitivity.

Table 4. Fisher's heterogeneity test for mixture distribution of within MZ twin pair differences of trajectory features broken by sex.

Intercept Linear slope


Na Estimates Rank-normalized estimates Na Estimates Rank-normalized estimates




Tb Pc Tb Pc Tb Pc Tb Pc
Men 917 8.72 <0.001 4.51 <0.001 332 5.39 <0.001 2.59 <0.01
Women 807 5.00 <0.001 4.23 <0.001 433 13.63 <0.001 6.51 <0.001

The analyses are adjusted for age at first assessment and study

Estimates are weighted Best Linear Unbiased Prediction estimates of trajectory features (see text)

a

Number of MZ pairs

b

Fisher's test statistic for deviance from normal distribution t=(d2¯π2d¯2)/s, where d2¯ is the mean of the squared within-pair difference, d¯ is the mean of within-pair difference, s=d2¯n0.532 is the standard error, and n is the number of MZ twin pairs

c

One-sided t test; n1 degrees of freedom

Table 5 reports Bartlett's test for equal variances of within MZ twin pair age and study adjusted differences of grip strength trajectory features in three APOE categories stratified by sex. Significant heterogeneity indicates that particular APOE haplotypes may be more or less sensitive to environmental factors, i.e., that environmental factors interact with haplotypes of the APOE gene. The results showed a trend of increasing variability of the trajectory features across APOE haplotype categories (from ε2+ to ε4+) in women. However, in men, the largest variability of the intercept was observed in APOE ε3ε3, and the variability of the slope was similar in the APOE ε3ε3 and APOE ε4+ groups. The only statistically significant result was found for the slope (p < 0.01) in women, but this was not retained in the analyses of the Winsorized or rank-normalized estimates, which indicates that the significance was driven by outliers. However, statistical strength was retained when the intercept estimate was rank normalized (p = 0.04). Notably, while Winsorization impacted the significance of the tests, it had little impact on the variances (results not shown).

Table 5. Bartlett's test for equal variances of within-pair differences, MZ twins only, of trajectory features in categories of APOE haplotypes.

APOE category N Variance of trajectory estimates (95 % CI) Bartlett's test for equal variances of trajectory features (p values)

Trajectory estimates Winsorized estimatesa Rank-normalized estimates
Men
 Intercept ε2ε2 or ε2ε3 86 1.85 (1.26;2.45) 0.32 0.58 0.48
ε3ε3 347 2.41 (1.89;2.92)
ε3ε4 or ε4ε4 183 2.23 (1.68;2.77)
 Linear slope ε2ε2 or ε2ε3 32 0.19 (0.11;0.28) 0.09 0.09 0.07
ε3ε3 115 0.37 (0.25;0.49)
ε3ε4 or ε4ε4 62 0.37 (0.20;0.54)
Women
 Intercept ε2ε2 or ε2ε3 69 1.75 (1.09;2.42) 0.06 0.08 0.04
ε3ε3 281 2.63 (2.07;3.19)
ε3ε4 or ε4ε4 139 2.94 (2.12;3.75)
 Linear slope ε2ε2 or ε2ε3 43 0.16 (0.03;0.30) <0.01 0.49 0.38
ε3ε3 172 0.21 (0.15;0.28)
ε3ε4 or ε4ε4 82 0.36 (0.06;0.65)

The analyses are adjusted for age at first assessment and study

Estimates are weighted Best Linear Unbiased Prediction estimates of trajectory features (see text)

a

Winsorization: absolute values greater than 3 SD are set to +/− 3SD respectively

Discussion

In the present study we examined grip strength trajectories in a large sample of twins pooled from seven surveys across four countries. The differences in mean levels of the trajectory features by APOE haplotype categories were small and statistically not significant in general. We found evidence of G×E interaction on the trajectory features. Moreover, our results suggest that the APOE gene might be a candidate gene for the G×E interaction. To our knowledge, this is the first study to address the question of G×E interaction in grip strength trajectories.

Previous studies of grip strength and APOE haplotypes found statistically non-significant tendencies towards lower grip strength in APOE ε2+ over APOE ε3ε3 to APOE ε4+ (Vasunilashorn et al. 2013; Alfred et al. 2014). In our study, we found that among men the intercept at age 70 was slightly lower in the APOE ε2+ group, but highest in the APOE ε3ε3 group. In women, the APOE ε2+ carriers showed greater and the APOE ε4+ carriers lower grip strength levels than APOE ε3ε3 carriers. Thus, our results do not confirm the tendencies found in previous studies. This might be due to the fact that we stratified the analyses by sex, whereas previous studies adjusted for sex, thereby possibly masking different directional trends in men and women. We did not observe any differences in linear slope across APOE haplotype categories. Consequently, despite the large sample sizes of our study, we did not strong evidence of any association between the APOE gene and mean of trajectory features.

The results from Fisher's test for mixture distribution of within-MZ-twin pair differences of the trajectory features (i.e. linear slope and intercept at age 70) demonstrated general evidence of G×E interaction for men and women. It is possible that the missing heritability of change in grip strength (Finkel et al. 2003) was obscured by the existence of G×E interaction since this would contribute to the unique environment and not the genetic variance components in heritability analyses.

Our study offered consistent, though not statistically significant, evidence that the variances of within-pair differences in trajectory parameters in MZ twins were smaller in the APOE ε2+ haplotype category than in the other categories. These results could suggest that, compared to other APOE haplotypes, carriers of the APOE ε2+ haplo-types may be less sensitive to (unspecified) unshared environmental factors, i.e., that there was an interaction between the APOE gene and unspecified environmental factors affecting the grip strength trajectories. This interpretation may be in line with previous studies suggesting that the APOE gene interacts with environmental factors on some phenotypes related to grip strength. Thus, in a study of earthquake victims it was shown that, 1 year after the earthquake, APOE ε4+ haplotypes had lower levels of self-rated health, mobility and IADL (Daly and MacLachlan 2011), and in another study of male twins, lower total cerebral brain volume was associated with worse physical performance (composite of walking speed, balance, and chair stand) in APOE ε4+ carriers than in APOE ε4 non-carriers (Carmelli et al. 2000).

Grip strength is a phenotype that has been associated primarily with late-life, age-related health outcomes. However, several studies have demonstrated that grip strength declines throughout midlife to late-life. Therefore, the growth curve modelling in our study was based on grip strength measurements of twins in a wide age range (34–99 years) applying curvilinear main effects of age. Thus, we took advantage of the wide age range to model the decline of grip strength throughout mid- to late-life. However, this approach also relied on the assumption that the G×E interaction was conserved across the age-range. We repeated the analyses stratified in two groups (those who were less than age 70 at intake and those who were age 70 or more at intake) which lowered the statistical power but the trends across APOE groups were preserved (results not shown).

The large sample of informative MZ twins is a major strength of the present study. Our analytical approach is powerful since it controls for genetic influences and any common environmental influences. The differing protocols for grip strength measurements in the various studies were a limitation of our study; therefore grip strength was standardized separately by study prior to growth curve modelling. Secondly, apart from three studies (SATSA, OCTO, and LSADT), the number of possible measurement occasions was less than three which did not allow us to estimate the individual differences in the quadratic growth curve parameter for acceleration or deceleration of decline. Hardy–Weinberg Equilibrium of the APOE gene was not confirmed in VETSA. However, performing a Chi squared test on the two single SNP's did not provide any evidence of a violation of the Hardy–Weinberg Equilibrium (both p > 0.05). Moreover, Hardy–Weinberg Equilibrium was not violated in the total sample. Thus, we did not expect the deviance from Hardy–Weinberg Equilibrium in the VETSA study to introduce any bias. Last, tests of equality of variances are beset by low power (e.g., (Martin et al. 1983)), which would have been of particular concern for tests of the linear slopes.

The analyses in our study were based on the maximum of the attempted grip strength measures. Alternatively, as is most commonly described in the literature, the average of the attempts could have been used. Previous studies of the validity of grip strength have demonstrated that grip strength decreased by each attempt suggesting increasing fatigue (Abizanda et al. 2012; Watanabe et al. 2005). However, allowing the participant to rest 1 min between each attempt gave stable outcomes of the attempts (Watanabe et al. 2005). Since each survey in our study has its own protocol for measuring grip strength, but none of the protocols specify any recommended rest interval between the attempts, we expected the maximum grip strength to be more reliable across studies than the average grip strength. Moreover, although it is possible to underestimate maximum grip strength, if maximum effort is not used, it is exceedingly difficult to conceive of a way that an individual could produce a grip strength result that was higher than his or her true maximum.

Further analyses on larger sample sizes should be performed to examine the possibility of an interaction between APOE (as well as other genes) and unspecified environmental factors on grip strength trajectories. Search for specific environmental factors whose effect on grip strength trajectories are modified by the APOE gene (or other genes) could be selected among those environmental factors that have been found to affect grip strength (e.g. smoking, socioeconomic status, education, early malnutrition, stature, strenuous work, and diseases) and, as suggested by Sternäng et al. (2014), different environmental factors may be involved for men and women.

Acknowledgments

IGEMS is supported by the National Institutes of Health grant No. R01 AG037985. SATSA was supported by grants R01 AG04563, R01 AG10175, the MacArthur Foundation Research Network on Successful Aging, the Swedish Council For Working Life and Social Research (FAS) (97:0147:1B, 2009-0795) and Swedish Research Council (825-2007-7460, 825-2009-6141). OCTO-Twin was supported by grant R01 AG08861. The Danish Twin Registry is supported by grants from The National Program for Research Infrastructure 2007 from the Danish Agency for Science Technology and Innovation, the Velux Foundation and the US National Institute of Health (P01 AG08761). VETSA was supported by National Institute of Health grants NIA R01 AG018384, R01 AG018386, R01 AG022381, and R01 AG022982, and, in part, with resources of the VA San Diego Center of Excellence for Stress and Mental Health. The Cooperative Studies Program of the Office of Research & Development of the United States Department of Veterans Affairs has provided financial support for the development and maintenance of the Vietnam Era Twin Registry. The MIDUS study was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development and by National Institute on Aging Grant AG20166. FITSA was supported by grants from the Academy of Finland (69818) and the Finnish Ministry of Education and Culture (120/722/2003).

Footnotes

Conflict of Interest The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent All procedures followed complied with the ethical standards. Informed consent were obtained for all participants.

References

  1. Abizanda P, Navarro JL, Garcia-Tomas MI, Lopez-Jimenez E, Martinez-Sanchez E, Paterna G. Validity and usefulness of hand-held dynamometry for measuring muscle strength in community-dwelling older persons. Arch Gerontol Geriatr. 2012;54(1):21–27. doi: 10.1016/j.archger.2011.02.006. [DOI] [PubMed] [Google Scholar]
  2. Alfred T, Ben-Shlomo Y, Cooper R, Hardy R, Cooper C, Deary IJ, Elliott J, Gunnell D, Harris SE, Kivimaki M, Kumari M, Martin RM, Power C, Sayer AA, Starr JM, Kuh D, Day IN. Associations between APOE and low-density lipoprotein cholesterol genotypes and cognitive and physical capability: the HALCyon programme. Age (Dordr) 2014;36(4):9673. doi: 10.1007/s11357-014-9673-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Batterham PJ, Bunce D, Cherbuin N, Christensen H. Apolipoprotein E epsilon4 and later-life decline in cognitive function and grip strength. Am J Geriatr Psychiatry. 2013;21(10):1010–1019. doi: 10.1016/j.jagp.2013.01.035. [DOI] [PubMed] [Google Scholar]
  4. Carmelli D, DeCarli C, Swan GE, Kelly-Hayes M, Wolf PA, Reed T, Guralnik JM. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. J Gerontol A Biol Sci Med Sci. 2000;55(2):M103–M109. doi: 10.1093/gerona/55.2.m103. [DOI] [PubMed] [Google Scholar]
  5. Christensen K, Holm NV, McGue M, Corder L, Vaupel JW. A Danish population-based twin study on general health in the elderly. J Aging Health. 1999;11(1):49–64. doi: 10.1177/089826439901100103. [DOI] [PubMed] [Google Scholar]
  6. Christiansen L, Frederiksen H, Schousboe K, Skytthe A, von WurmbSchwark N, Christensen K, Kyvik K. Age- and sex-differences in the validity of questionnaire-based zygosity in twins. Twin Res. 2003;6(4):275–278. doi: 10.1375/136905203322296610. [DOI] [PubMed] [Google Scholar]
  7. College Station TX: StataCorp LP. Stata: release 13 Statistical software. StataCorp LP: College Station, TX; 2013. [Google Scholar]
  8. Cooper R, Strand BH, Hardy R, Patel KV, Kuh D. Physical capability in mid-life and survival over 13 years of follow-up: British birth cohort study. BMJ. 2014;348:g2219. doi: 10.1136/bmj.g2219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010a;39(4):412–423. doi: 10.1093/ageing/afq034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cruz-Jentoft AJ, Landi F, Topinkova E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010b;13(1):1–7. doi: 10.1097/MCO.0b013e328333c1c1. [DOI] [PubMed] [Google Scholar]
  11. Daly M, MacLachlan M. Heredity links natural hazards and human health: apolipoprotein E gene moderates the health of earthquake survivors. Health Psychol. 2011;30(2):228–235. doi: 10.1037/a0022377. [DOI] [PubMed] [Google Scholar]
  12. den Ouden ME, Schuurmans MJ, Mueller-Schotte S, van der Schouw YT. Identification of high-risk individuals for the development of disability in activities of daily living. A ten-year follow-up study. Exp Gerontol. 2013;48(4):437–443. doi: 10.1016/j.exger.2013.02.002. [DOI] [PubMed] [Google Scholar]
  13. Felicio DC, Pereira DS, Assumpcao AM, de Jesus-Moraleida FR, de Queiroz BZ, da Silva JP, de Brito Rosa NM, Dias JM, Pereira LS. Poor correlation between handgrip strength and isokinetic performance of knee flexor and extensor muscles in community-dwelling elderly women. Geriatr Gerontol Int. 2014;14(1):185–189. doi: 10.1111/ggi.12077. [DOI] [PubMed] [Google Scholar]
  14. Finkel D, Pedersen NL, Reynolds CA, Berg S, de Faire U, Svartengren M. Genetic and environmental influences on decline in biobehavioral markers of aging. Behav Genet. 2003;33(2):107–123. doi: 10.1023/a:1022549700943. [DOI] [PubMed] [Google Scholar]
  15. Fisher RA. The resemblance between twins, a statistical examination of Lauterbach's measurements. Genetics. 1925;10(6):569–579. doi: 10.1093/genetics/10.6.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Frederiksen H, Gaist D, Petersen HC, Hjelmborg J, McGue M, Vaupel JW, Christensen K. Hand grip strength: a phenotype suitable for identifying genetic variants affecting mid- and late-life physical functioning. Genet Epidemiol. 2002;23(2):110–122. doi: 10.1002/gepi.1127. [DOI] [PubMed] [Google Scholar]
  17. Frederiksen H, Hjelmborg J, Mortensen J, McGue M, Vaupel JW, Christensen K. Age trajectories of grip strength: cross-sectional and longitudinal data among 8,342 Danes aged 46 to 102. Ann Epidemiol. 2006;16(7):554–562. doi: 10.1016/j.annepidem.2005.10.006. [DOI] [PubMed] [Google Scholar]
  18. Gatz M, Reynolds CA, Finkel D, Pedersen NL, Walters E. Dementia in Swedish twins: predicting incident cases. Behav Genet. 2010;40(6):768–775. doi: 10.1007/s10519-010-9407-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kendler KS, Thornton LM, Gilman SE, Kessler RC. Sexual orientation in a U.S. national sample of twin and nontwin sibling pairs. Am J Psychiatry. 2000;157(11):1843–1846. doi: 10.1176/appi.ajp.157.11.1843. [DOI] [PubMed] [Google Scholar]
  20. Kremen WS, Franz CE, Lyons MJ. VETSA: the Vietnam era twin study of aging. Twin Res Hum Genet. 2013;16(1):399–402. doi: 10.1017/thg.2012.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Krueger RF, Johnson W. The Minnesota twin registry: current status and future directions. Twin Res. 2002;5(5):488–492. doi: 10.1375/136905202320906336. [DOI] [PubMed] [Google Scholar]
  22. Kulminski A, Ukraintseva SV, Arbeev KG, Manton KG, Oshima J, Martin GM, Yashin AI. Association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphism and disability severity in a national long-term care survey sample. Age Ageing. 2008;37(3):288–293. doi: 10.1093/ageing/afn003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Legrand D, Vaes B, Mathei C, Adriaensen W, Van PG, Degryse JM. Muscle strength and physical performance as predictors of mortality, hospitalization, and disability in the oldest old. J Am Geriatr Soc. 2014;62(6):1030–1038. doi: 10.1111/jgs.12840. [DOI] [PubMed] [Google Scholar]
  24. Lichtenstein P, de Faire U, Floderus B, Svartengren M, Svedberg P, Pedersen NL. The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med. 2002;252(3):184–205. doi: 10.1046/j.1365-2796.2002.01032.x. [DOI] [PubMed] [Google Scholar]
  25. Ludwig O. Blom, Gunnar: statistical estimates and transformed beta-variables. Wiley/New York, Almquist und Wiksell/Stockholm 1958. Biom Z. 1961;3(4):285. [Google Scholar]
  26. Martin NG, Rowell DM, Whitfield JB. Do the MN and Jk systems influence environmental variability in serum lipid levels? Clin Genet. 1983;24(1):1–14. doi: 10.1111/j.1399-0004.1983.tb00061.x. [DOI] [PubMed] [Google Scholar]
  27. McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA, Plomin R. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science. 1997;276(5318):1560–1563. doi: 10.1126/science.276.5318.1560. [DOI] [PubMed] [Google Scholar]
  28. McGue M, Christensen K. Growing old but not growing apart: twin similarity in the latter half of the lifespan. Behav Genet. 2013;43(1):1–12. doi: 10.1007/s10519-012-9559-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mendes J, Azevedo A, Amaral TF. Handgrip strength at admission and time to discharge in medical and surgical inpatients. JPEN: J Parenter Enteral Nutr. 2014;38(4):481–488. doi: 10.1177/0148607113486007. [DOI] [PubMed] [Google Scholar]
  30. Nahhas RW, Choh AC, Lee M, Chumlea WM, Duren DL, Siervogel RM, Sherwood RJ, Towne B, Czerwinski SA. Bayesian longitudinal plateau model of adult grip strength. Am J Hum Biol. 2010;22(5):648–656. doi: 10.1002/ajhb.21057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Pedersen NL, McClearn GE, Plomin R, Nesselroade JR, Berg S, DeFaire U. The Swedish Adoption Twin Study of Aging: an update. Acta Genet Med Gemellol (Roma) 1991;40(1):7–20. doi: 10.1017/s0001566000006681. [DOI] [PubMed] [Google Scholar]
  32. Pedersen NL, Christensen K, Dahl AK, Finkel D, Franz CE, Gatz M, Horwitz BN, Johansson B, Johnson W, Kremen WS, Lyons MJ, Malmberg B, McGue M, Neiderhiser JM, Petersen I, Reynolds CA. IGEMS: the consortium on Interplay of Genes and Environment across Multiple Studies. Twin Res Hum Genet. 2013;16(1):481–489. doi: 10.1017/thg.2012.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Proctor DN, Fauth EB, Hoffman L, Hofer SM, McClearn GE, Berg S, Johansson B. Longitudinal changes in physical functional performance among the oldest old: insight from a study of Swedish twins. Aging Clin Exp Res. 2006;18(6):517–530. doi: 10.1007/BF03324853. [DOI] [PubMed] [Google Scholar]
  34. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb JD, White L. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281(6):558–560. doi: 10.1001/jama.281.6.558. [DOI] [PubMed] [Google Scholar]
  35. Rantanen T, Harris T, Leveille SG, Visser M, Foley D, Masaki K, Guralnik JM. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci. 2000;55(3):M168–M173. doi: 10.1093/gerona/55.3.m168. [DOI] [PubMed] [Google Scholar]
  36. Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc. 2003;51(5):636–641. doi: 10.1034/j.1600-0579.2003.00207.x. [DOI] [PubMed] [Google Scholar]
  37. Rantanen T, Masaki K, He Q, Ross GW, Willcox BJ, White L. Midlife muscle strength and human longevity up to age 100 years: a 44-year prospective study among a decedent cohort. Age (Dordr) 2012;34(3):563–570. doi: 10.1007/s11357-011-9256-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Reynolds CA, Gatz M, Berg S, Pedersen NL. Genotype-environment interactions: cognitive aging and social factors. Twin Res Hum Genet. 2007;10(2):241–254. doi: 10.1375/twin.10.2.241. [DOI] [PubMed] [Google Scholar]
  39. Reynolds CA, Zavala C, Gatz M, Vie L, Johansson B, Malmberg B, Ingelsson E, Prince JA, Pedersen NL. Sortilin receptor 1 predicts longitudinal cognitive change. Neurobiol Aging. 2013;34(6):1710–1718. doi: 10.1016/j.neurobiolaging.2012.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sayer AA, Robinson SM, Patel HP, Shavlakadze T, Cooper C, Grounds MD. New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age Ageing. 2013;42(2):145–150. doi: 10.1093/ageing/afs191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schultz MR, Lyons MJ, Franz CE, Grant MD, Boake C, Jacobson KC, Xian H, Schellenberg GD, Eisen SA, Kremen WS. Apolipoprotein E genotype and memory in the sixth decade of life. Neurology. 2008;70(19 Pt 2):1771–1777. doi: 10.1212/01.wnl.0000286941.74372.cc. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Silventoinen K, Magnusson PK, Tynelius P, Kaprio J, Rasmussen F. Heritability of body size and muscle strength in young adulthood: a study of one million Swedish men. Genet Epidemiol. 2008;32(4):341–349. doi: 10.1002/gepi.20308. [DOI] [PubMed] [Google Scholar]
  43. Skytthe A, Kyvik K, Holm NV, Vaupel JW, Christensen K. The Danish Twin Registry: 127 birth cohorts of twins. Twin Res. 2002;5(5):352–357. doi: 10.1375/136905202320906084. [DOI] [PubMed] [Google Scholar]
  44. Skytthe A, Christiansen L, Kyvik KO, Bodker FL, Hvidberg L, Petersen I, Nielsen MM, Bingley P, Hjelmborg J, Tan Q, Holm NV, Vaupel JW, McGue M, Christensen K. The Danish Twin Registry: linking surveys, national registers, and biological information. Twin Res Hum Genet. 2013;16(1):104–111. doi: 10.1017/thg.2012.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sternang O, Reynolds CA, Finkel D, Ernsth-Bravell M, Pedersen NL, Aslan AKD. Factors associated with grip strength decline in older adults. Age Ageing. 2015a;44(2):269–274. doi: 10.1093/ageing/afu170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sternang O, Reynolds CA, Finkel D, Ernsth-Bravell M, Pedersen NL, Aslan AKD. Grip strength and cognitive abilities: associations in old age. J Gerontol B Psychol Sci Soc Sci. 2015b doi: 10.1093/geronb/gbv017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Syddall H, Cooper C, Martin F, Briggs R, Aihie SA. Is grip strength a useful single marker of frailty? Age Ageing. 2003;32(6):650–656. doi: 10.1093/ageing/afg111. [DOI] [PubMed] [Google Scholar]
  48. Taekema DG, Gussekloo J, Maier AB, Westendorp RG, de Craen AJ. Handgrip strength as a predictor of functional, psychological and social health. A prospective population-based study among the oldest old. Age Ageing. 2010;39(3):331–337. doi: 10.1093/ageing/afq022. [DOI] [PubMed] [Google Scholar]
  49. Tiainen K, Sipila S, Alen M, Heikkinen E, Kaprio J, Koskenvuo M, Tolvanen A, Pajala S, Rantanen T. Heritability of maximal isometric muscle strength in older female twins. J Appl Physiol (1985) 2004;96(1):173–180. doi: 10.1152/japplphysiol.00200.2003. [DOI] [PubMed] [Google Scholar]
  50. van Milligen BA, Vogelzangs N, Smit JH, Penninx BW. Physical function as predictor for the persistence of depressive and anxiety disorders. J Affect Disord. 2012;136(3):828–832. doi: 10.1016/j.jad.2011.09.030. [DOI] [PubMed] [Google Scholar]
  51. Vasunilashorn S, Glei DA, Lin YH, Goldman N. Apolipoprotein E and measured physical and pulmonary function in older Taiwanese adults. Biodemography Soc Biol. 2013;59(1):57–67. doi: 10.1080/19485565.2013.778703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Watanabe T, Owashi K, Kanauchi Y, Mura N, Takahara M, Ogino T. The short-term reliability of grip strength measurement and the effects of posture and grip span. J Hand Surg Am. 2005;30(3):603–609. doi: 10.1016/j.jhsa.2004.12.007. [DOI] [PubMed] [Google Scholar]

RESOURCES